Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-25 @ 1:27 AM
NCT ID:
NCT02366494
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven prostate cancer.
* Testosterone level \>30ng/ml and at least 6 months since last dose of hormonal therapy.
* History/physical examination including a detailed description of the stage of prostate cancer within 8 weeks prior to registration.
* CT scan of abdomen and pelvis with IV contrast and bone scan should be performed within 8 weeks prior to registration.
* Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2.
* Age ≥ 18.
* Patients must provide study-specific informed consent prior to study entry for this project and mandatory blood specimen for banking for future studies (future studies may include genetic testing).
Exclusion Criteria:
* Received hormonal therapy less than 6 months prior to registration.
* History of active secondary malignancy.
* Decline hormone therapy for prostate cancer.
* Current or previous treatment with 5-alpha reductase inhibitors within 6 months prior to enrollment.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
21 Years
Maximum Age:
85 Years
Study:
NCT02366494
Study Brief:
Protocol Section:
NCT02366494